Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11519004 Transcription modulation in animals using CRISPR/Cas systems
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
March 19, 2019
Date of Patent
December 6, 2022
Patent Applicant
Regeneron Pharmaceuticals
Patent Application Number
16358395
Patent Citations
US Patent 11001829 Functional screening with optimized functional CRISPR-Cas systems
US Patent 10760064 RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US Patent 10329582 Genetic modification of rats
US Patent 10385359 Targeted modification of rat genome
US Patent 10550372 Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems
US Patent 10577630 Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11519004
Patent Primary Examiner
Arthur S Leonard
Find more entities like US Patent 11519004 Transcription modulation in animals using CRISPR/Cas systems
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE